EUVIMEDEUVIMED entdecken
Crossref

Linoleic acid derivatives target miR‐361‐3p/BTG2 to confer anticancer effects in acute myeloid leukemia

Shili Liu, Huijuan Xu, Zhen Li

Journal of Biochemical and Molecular Toxicology · 2023-11 · 37 (11)

DOI: 10.1002/jbt.23481 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Biochemical and Molecular Toxicology, online erschienen am 27.07.2023. Verfasst von Shili Liu und 2 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory Medicine and Biotechnology, Southern Medical University, Guangzhou, Guangdong Province, People's Republic of China. Hauptthemen laut MEDLINE: MicroRNAs, Leukemia, Myeloid, Acute, Immediate-Early Proteins. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 37 Literaturangaben. Gefördert von: National Nature Science Foundation of China, Guangzhou Science and Technology Project.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Acute myeloid leukemia (AML) is a deadly hematologic malignancy. In this study, miR‐361‐3p and BTG2 gene expression in AML blood and healthy specimens were analyzed using quantitative real‐time reverse transcription polymerase chain reaction. A significant negative correlation between miR‐361‐3p and BTG2 was observed. The cell viability and apoptosis were measured by CCK‐8 assay, EdU incorporation assay and flow cytometry. A dual‐luciferase reporter gene assay was performed to confirm the binding sequence between miR‐361‐3p and BTG2 messenger RNA 3ʹ‐untranslated region. 9s‐Hydroxyoctadecadienoic acid (9s‐HODE), a major active derivative of linoleic acid, reduced the viability and induced cell apoptosis of HL‐60 cells. Furthermore, the miR‐361‐3p mimics and siBTG2 reversed the above effects of 9s‐HODE. 9s‐HODE exerted an anti‐AML effect through, at least partly, regulating the miR‐361‐3p/BTG2 axis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MicroRNAsLeukemia, Myeloid, AcuteImmediate-Early ProteinsHumansLinoleic AcidCell ProliferationHL-60 CellsApoptosisCell Line, TumorTumor Suppressor Proteins

Stichwörter der Autor:innen

9s-Hydroxyoctadecadienoic acidBTG2acute myeloid leukemiamiR-361-3p

Substanzen

MicroRNAsLinoleic AcidBTG2 protein, humanImmediate-Early ProteinsTumor Suppressor ProteinsMIRN361 microRNA, human

Autor:innen und Institutionen

  • Laboratory Medicine and Biotechnology, Southern Medical University, Guangzhou, Guangdong Province, People's Republic of China.
  • Clinical Laboratory, Suizhou Central Hospital, Suizhou, Hubei Province, People's Republic of China.
  • Department of Hematology, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong Province, People's Republic of China.

Förderung

  • National Nature Science Foundation of China
  • Guangzhou Science and Technology Project

Zitieren

APA

Liu, S., Xu, H., & Li, Z. (2023). Linoleic acid derivatives target miR‐361‐3p/BTG2 to confer anticancer effects in acute myeloid leukemia. Journal of Biochemical and Molecular Toxicology, 37(11). https://doi.org/10.1002/jbt.23481

Vancouver

Liu S, Xu H, Li Z. Linoleic acid derivatives target miR‐361‐3p/BTG2 to confer anticancer effects in acute myeloid leukemia. Journal of Biochemical and Molecular Toxicology. 2023;37(11). doi:10.1002/jbt.23481

BibTeX
@article{Liu2023,
  author = {Liu, Shili and Xu, Huijuan and Li, Zhen},
  title = {Linoleic acid derivatives target miR‐361‐3p/BTG2 to confer anticancer effects in acute myeloid leukemia},
  journal = {Journal of Biochemical and Molecular Toxicology},
  year = {2023},
  volume = {37},
  number = {11},
  doi = {10.1002/jbt.23481}
}
Kostenlos starten →